| Experimental Factor Ontology (EFO) Information | |
| Identifier | EFO_0004467 |
| Description | An insulin measurement is a measure of insulin typically performed in the diagnosis of patients | Trait category |
Other measurement
|
| Synonym | insulin level |
| Child trait(s) | 7 child traits |
| Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
|---|---|---|---|---|---|---|
| PGS000308 (GRS12_FIadjBMI) |
PGP000092 | Xie T et al. Circ Genom Precis Med (2020) |
Fasting insulin (body mass index adjusted) | BMI-adjusted fasting blood insulin measurement | 12 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000308/ScoringFiles/PGS000308.txt.gz |
| PGS000834 (CIR) |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Corrected insulin response (at 30mins during OGTT) | insulin response measurement | 220 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000834/ScoringFiles/PGS000834.txt.gz |
| PGS000837 (ISI) |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Insulin sensitivity index | insulin sensitivity measurement | 219 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000837/ScoringFiles/PGS000837.txt.gz |
| PGS000840 (Fasting_Proinsulin) |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Fasting Proinsulin | proinsulin measurement | 223 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000840/ScoringFiles/PGS000840.txt.gz |
| PGS001117 (GBE_BIN_FC10002986) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Started insulin within one year diagnosis of diabetes | insulin use measurement | 68 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001117/ScoringFiles/PGS001117.txt.gz |
| PGS003469 (LDPred2_HOMA_B) |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
HOMA-B | HOMA-B | 775,825 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003469/ScoringFiles/PGS003469.txt.gz |
| PGS003470 (LDPred2_HOMA_IR) |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
HOMA-IR | HOMA-IR | 775,999 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003470/ScoringFiles/PGS003470.txt.gz |
| PGS005276 (FI_PS_EUR) |
PGP000750 | Sarnowski C et al. Commun Biol (2025) |
Fasting insulin adjusted for BMI | BMI-adjusted fasting blood insulin measurement | 1,116,555 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS005276/ScoringFiles/PGS005276.txt.gz | |
| PGS005277 (FI_PS_AFR) |
PGP000750 | Sarnowski C et al. Commun Biol (2025) |
Fasting insulin adjusted for BMI | BMI-adjusted fasting blood insulin measurement | 1,233,791 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS005277/ScoringFiles/PGS005277.txt.gz | |
| PGS005278 (FI_PS_AMR) |
PGP000750 | Sarnowski C et al. Commun Biol (2025) |
Fasting insulin adjusted for BMI | BMI-adjusted fasting blood insulin measurement | 1,182,208 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS005278/ScoringFiles/PGS005278.txt.gz |
|
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|---|
| PPM000778 | PGS000308 (GRS12_FIadjBMI) |
PSS000376| European Ancestry| 1,354 individuals |
PGP000092 | Xie T et al. Circ Genom Precis Med (2020) |
Reported Trait: Fasting insulin (mU/I) | — | — | R²: 0.0069 | Sex, age, BMI | — |
| PPM002253 | PGS000834 (CIR) |
PSS001086| European Ancestry| 3,194 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Severe Autoimmune Diabetes | OR: 0.98 [0.89, 1.08] | — | — | PC1-10 | — |
| PPM002254 | PGS000834 (CIR) |
PSS001087| European Ancestry| 3,930 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Severe Insulin-Deficient Diabetes | OR: 0.76 [0.71, 0.82] | — | — | PC1-10 | — |
| PPM002255 | PGS000834 (CIR) |
PSS001088| European Ancestry| 3,869 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Severe Insulin-Resistant Diabetes | OR: 1.02 [0.95, 1.09] | — | — | PC1-10 | — |
| PPM002256 | PGS000834 (CIR) |
PSS001085| European Ancestry| 4,116 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Moderate Obesity-related Diabetes | OR: 0.79 [0.74, 0.85] | — | — | PC1-10 | — |
| PPM002257 | PGS000834 (CIR) |
PSS001084| European Ancestry| 5,597 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Moderate Age-Related Diabetes | OR: 0.82 [0.77, 0.86] | — | — | PC1-10 | — |
| PPM020169 | PGS000834 (CIR) |
PSS011301| South Asian Ancestry| 1,282 individuals |
PGP000525 | Yajnik CS et al. Lancet Reg Health Southeast Asia (2023) |Ext. |
Reported Trait: Type 2 diabetes | OR: 0.72 [0.6, 0.85] | — | — | age, sex and BMI | — |
| PPM020189 | PGS000834 (CIR) |
PSS011302| South Asian Ancestry| 830 individuals |
PGP000525 | Yajnik CS et al. Lancet Reg Health Southeast Asia (2023) |Ext. |
Reported Trait: Severe insulin deficiency diabetes | OR: 0.86 [0.75, 0.99] | — | — | sex | — |
| PPM020198 | PGS000834 (CIR) |
PSS011303| South Asian Ancestry| 729 individuals |
PGP000525 | Yajnik CS et al. Lancet Reg Health Southeast Asia (2023) |Ext. |
Reported Trait: Mild obesity-related diabetes | OR: 0.85 [0.73, 1.0] | — | — | sex | — |
| PPM002268 | PGS000837 (ISI) |
PSS001086| European Ancestry| 3,194 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Severe Autoimmune Diabetes | OR: 0.92 [0.83, 1.01] | — | — | PC1-10 | — |
| PPM002269 | PGS000837 (ISI) |
PSS001087| European Ancestry| 3,930 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Severe Insulin-Deficient Diabetes | OR: 0.93 [0.86, 0.99] | — | — | PC1-10 | — |
| PPM002270 | PGS000837 (ISI) |
PSS001088| European Ancestry| 3,869 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Severe Insulin-Resistant Diabetes | OR: 0.84 [0.79, 0.91] | — | — | PC1-10 | — |
| PPM002271 | PGS000837 (ISI) |
PSS001085| European Ancestry| 4,116 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Moderate Obesity-related Diabetes | OR: 0.88 [0.82, 0.94] | — | — | PC1-10 | — |
| PPM002272 | PGS000837 (ISI) |
PSS001084| European Ancestry| 5,597 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Moderate Age-Related Diabetes | OR: 0.95 [0.9, 1.0] | — | — | PC1-10 | — |
| PPM020179 | PGS000837 (ISI) |
PSS011301| South Asian Ancestry| 1,282 individuals |
PGP000525 | Yajnik CS et al. Lancet Reg Health Southeast Asia (2023) |Ext. |
Reported Trait: HOMA2IR | β: -0.09902 (0.047574) | — | — | — | — |
| PPM002283 | PGS000840 (Fasting_Proinsulin) |
PSS001086| European Ancestry| 3,194 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Severe Autoimmune Diabetes | OR: 0.91 [0.82, 1.01] | — | — | PC1-10 | — |
| PPM002285 | PGS000840 (Fasting_Proinsulin) |
PSS001088| European Ancestry| 3,869 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Severe Insulin-Resistant Diabetes | OR: 1.04 [0.97, 1.11] | — | — | PC1-10 | — |
| PPM002286 | PGS000840 (Fasting_Proinsulin) |
PSS001085| European Ancestry| 4,116 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Moderate Obesity-related Diabetes | OR: 1.06 [1.0, 1.14] | — | — | PC1-10 | — |
| PPM002287 | PGS000840 (Fasting_Proinsulin) |
PSS001084| European Ancestry| 5,597 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Moderate Age-Related Diabetes | OR: 1.07 [1.01, 1.12] | — | — | PC1-10 | — |
| PPM002284 | PGS000840 (Fasting_Proinsulin) |
PSS001087| European Ancestry| 3,930 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Severe Insulin-Deficient Diabetes | OR: 1.11 [1.04, 1.19] | — | — | PC1-10 | — |
| PPM008323 | PGS001117 (GBE_BIN_FC10002986) |
PSS003731| African Ancestry| 705 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Started insulin within one year diagnosis of diabetes | — | AUROC: 0.6057 [0.54935, 0.66205] | R²: 0.03335 Incremental AUROC (full-covars): 0.01803 PGS R2 (no covariates): 0.00453 PGS AUROC (no covariates): 0.54401 [0.48567, 0.60235] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM008324 | PGS001117 (GBE_BIN_FC10002986) |
PSS003732| East Asian Ancestry| 86 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Started insulin within one year diagnosis of diabetes | — | AUROC: 0.71573 [0.51412, 0.91734] | R²: 0.15018 Incremental AUROC (full-covars): -0.09668 PGS R2 (no covariates): 0.11116 PGS AUROC (no covariates): 0.29582 [0.14557, 0.44606] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM008325 | PGS001117 (GBE_BIN_FC10002986) |
PSS003733| European Ancestry| 1,089 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Started insulin within one year diagnosis of diabetes | — | AUROC: 0.80203 [0.75876, 0.8453] | R²: 0.28861 Incremental AUROC (full-covars): 0.05722 PGS R2 (no covariates): 0.17586 PGS AUROC (no covariates): 0.72657 [0.67703, 0.77611] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM008326 | PGS001117 (GBE_BIN_FC10002986) |
PSS003734| South Asian Ancestry| 1,358 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Started insulin within one year diagnosis of diabetes | — | AUROC: 0.62878 [0.57833, 0.67923] | R²: 0.03294 Incremental AUROC (full-covars): 0.02324 PGS R2 (no covariates): 0.01621 PGS AUROC (no covariates): 0.58662 [0.53076, 0.64248] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM008327 | PGS001117 (GBE_BIN_FC10002986) |
PSS003735| European Ancestry| 3,243 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Started insulin within one year diagnosis of diabetes | — | AUROC: 0.74056 [0.71173, 0.76938] | R²: 0.17764 Incremental AUROC (full-covars): 0.0941 PGS R2 (no covariates): 0.12982 PGS AUROC (no covariates): 0.71086 [0.68153, 0.74018] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM017280 | PGS003469 (LDPred2_HOMA_B) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Respiratory event index | β: 0.002 (0.01) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
| PPM017303 | PGS003469 (LDPred2_HOMA_B) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Obstructive sleep apnea | β: 0.023 (0.024) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
| PPM017348 | PGS003469 (LDPred2_HOMA_B) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Respiratory event index in obsese | β: 0.025 (0.017) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
| PPM017368 | PGS003469 (LDPred2_HOMA_B) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Obstructive sleep apnea in obsese | β: 0.049 (0.034) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
| PPM017369 | PGS003469 (LDPred2_HOMA_B) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Obstructive sleep apnea in non-obsese | β: -0.007 (0.035) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
| PPM017396 | PGS003469 (LDPred2_HOMA_B) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Respiratory event index x obesity interaction | β: 0.041 (1.042) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
| PPM017349 | PGS003469 (LDPred2_HOMA_B) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Respiratory event index in non-obsese | β: -0.016 (0.012) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
| PPM017406 | PGS003469 (LDPred2_HOMA_B) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Obstructive sleep apnea x obesity interaction | β: 1.041 (0.049) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
| PPM017281 | PGS003470 (LDPred2_HOMA_IR) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Respiratory event index | β: 0.003 (0.011) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
| PPM017304 | PGS003470 (LDPred2_HOMA_IR) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Obstructive sleep apnea | β: 0.006 (0.025) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
| PPM022760 | PGS005276 (FI_PS_EUR) |
PSS012072| European Ancestry| 13,712 individuals |
PGP000750 | Sarnowski C et al. Commun Biol (2025) |
Reported Trait: Homeostasis Model Assessment for Insulin Resistance [HOMA-IR] | β: 0.237 | — | R²: 0.1076 | age, sex, study, BMI, and the first 11 genetic principal components | Score was standardized |
| PPM022761 | PGS005277 (FI_PS_AFR) |
PSS012073| African Ancestry| 4,695 individuals |
PGP000750 | Sarnowski C et al. Commun Biol (2025) |
Reported Trait: Homeostasis Model Assessment for Insulin Resistance [HOMA-IR] | β: 0.129 | — | R²: 0.0172 | age, sex, study, BMI, and the first 11 genetic principal components | Score was standardized |
| PPM022762 | PGS005278 (FI_PS_AMR) |
PSS012074| Hispanic or Latin American Ancestry| 1,693 individuals |
PGP000750 | Sarnowski C et al. Commun Biol (2025) |
Reported Trait: Homeostasis Model Assessment for Insulin Resistance [HOMA-IR] | β: 0.033 | — | R²: 0.0028 | age, sex, study, BMI, and the first 11 genetic principal components | Score was standardized |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS012073 | — | — | 4,695 individuals | — | African American or Afro-Caribbean | — | TOPMed | — |
| PSS012074 | — | — | 1,693 individuals | — | Hispanic or Latin American | — | TOPMed | — |
| PSS003731 | — | — | [
|
— | African unspecified | — | UKB | — |
| PSS003732 | — | — | [
|
— | East Asian | — | UKB | — |
| PSS003735 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
| PSS003733 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
| PSS011301 | — | — | [
|
— | South Asian (Indian) |
— | WellGen | — |
| PSS000376 | We measured weight and height using regularly calibrated equipment (scales and stadiometer models 770 and 214, respectively; Seca, Hamburg, Germany). Body mass index (BMI; in kg/m2) was also calculated. We measured waist circumference at the midpoint between the lower costal margin and the iliac crest. The hip circumference was measured over both trochanter majores (tangible bone on the outside of the hip joint). Waist to hip ratio was also calculated. We performed all measurements in duplicate, and, if the difference between these measurements exceeded a predefined value, a third measurement was performed. All available measurements were used to calculate means. Heart rate, systolic (SBP) and diastolic (DBP) blood pressure were measured in duplicate with a Dinamap Critikon 1846SX (Critikon Inc, Tampa, FL), from which we calculated means. At the third visit, fasting blood sample of participants were drawn for the measurement of glucose (Roche Diagnostics, Basel, Switzerland), insulin (Diagnostic Systems Laboratories Inc, Webster, TX), HbA1c (high performance liquid chromatography, Variant, Bio-Rad), triglycerides, total cholesterol, HDL cholesterol (Roche Diagnostics) and LDL cholesterol (calculated according to Friedewald’s equation5), as well as alanine transaminase (Photometric determination according to the reference method of the International Federation of Clinical Chemistry (IFCC)6) and lipoprotein(a) (Nephelometric method, BN2, DadeBehring). Serum creatinine was measured by photometric determination with the Jaffé method without deproteinisation (Ecoline® MEGA, DiaSys Diagnostic Systems GmbH. Merck). eGFR for adolescents who were younger than 18 years old was calculated using the Schwartz formula.7 High‐sensitivity C‐reactive protein (hsCRP) was determined using an immunonephelometric method, BN2 (CardioPhase hsCRP, Siemens) with a lower detection limit of 0.175 mg/L. Total IgE measurements were performed using the Phadia Immunocap 100 system with fluoroenzyme immunoassay (FEIA). | — | 1,354 individuals, 47.56 % Male samples |
Mean = 16.22 years Sd = 0.66 years |
European | — | TRAILS | — |
| PSS011302 | — | — | [
|
— | South Asian (Indian) |
— | WellGen | — |
| PSS011303 | — | — | [
|
— | South Asian (Indian) |
— | WellGen | — |
| PSS001084 | Moderate Age-Related Diabetes (MARD) vs. controls | — | [
|
— | European | Swedish | ANDIS | — |
| PSS001085 | Moderate Obesity-related Diabetes (MOD) vs. controls | — | [
|
— | European | Swedish | ANDIS | — |
| PSS001086 | Severe Autoimmune Diabetes (SAID) vs. controls | — | [
|
— | European | Swedish | ANDIS | — |
| PSS001087 | Severe Insulin-Deficient Diabetes (SIDD) vs. controls | — | [
|
— | European | Swedish | ANDIS | — |
| PSS001088 | Severe Insulin-Resistant Diabetes (SIRD) vs. controls | — | [
|
— | European | Swedish | ANDIS | — |
| PSS003734 | — | — | [
|
— | South Asian | — | UKB | — |
| PSS010185 | — | — | 1,115 individuals, 41.1 % Male samples |
Mean = 46.18 years | Hispanic or Latin American | — | HCHS-SOL | — |
| PSS012072 | — | — | 13,712 individuals | — | European | — | TOPMed | — |